Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Advanced Clinical Announces New Executive Vice President

Published: Monday, April 22, 2013
Last Updated: Monday, April 22, 2013
Bookmark and Share
Julie A. Ross appointed as Executive Vice President, CRO Operations.

Advanced Clinical has announced an addition to its leadership team: Julie A. Ross, has been hired as Executive Vice President, CRO Operations.

Julie Ross is a tenured executive leader who has been instrumental in the development and the success of multiple clinical operations divisions.

Previously with inVentiv Health Clinical (formerly Pharmanet/i3), Ms. Ross served as Senior Vice President, Global Strategic Services and had oversight of Feasibility, Patient Recruitment and Retention, Global Study Start-up, Document Management and Publishing, Expedited Safety Reporting, Grants and Contracts, Clinical Trial Supply Management and Medical Writing.

Prior to her role at inVentiv, Ms. Ross led Essential Group, a full-service CRO and patient recruitment company, which she helped build and position for its acquisition by inVentiv Health.

“We are very excited to welcome Julie to the Advanced Clinical team,” said Leo Sheridan, CEO of Advanced Clinical. “We are honored to bring Julie’s caliber and experience to our team as we continue expanding our CRO solutions. Her diverse knowledge and expertise in clinical research, as well as her strong leadership skills, are a perfect fit for Advanced Clinical.”

A graduate of the University of Wisconsin, La Crosse with a bachelor's degree in Nuclear Medicine Technology, Ms. Ross has been in the clinical research industry for over twenty five years.

She has authored many clinical research articles and is a well-known industry speaker. Ms. Ross will be based out of Advanced Clinical’s headquarters in Deerfield, IL.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,500+ scientific posters on ePosters
  • More than 5,000+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Drug to Treat Alcohol Use Disorder Shows Promise Among Drinkers With High Stress
The findings suggest that potential future studies with drugs targeting vasopressin blockade should focus on populations of people with AUD who also report high levels of stress.
Scientists Find Lethal Vulnerability in Treatment-Resistant Lung Cancer
The study describes how the drug Selinexor killed lung cancer cells and shrank tumors in mice when used against cancers driven by the aggressive and difficult-to-treat KRAS cancer gene.
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!